2-Methyl-2H-benzo[b][1,4]oxazin-3(4H)-one, 95.0%, 25g

4-(2-Oxopiperidin-1-yl)benzoic acid, 95+%, 250mg

1,4-Dihydronaphthalene, 97%, 1g

(2R,3S,4R)-2-(((Triisopropylsilyl)oxy)methyl)-3,4-dihydro-2H-pyran-3,4-diol, 95.0%, 25mg

2-[Bis(2-chloroethyl)amino]-1,3,2-oxazaphosphinan-2-one hydrate, 97.0%, 25g

Oxyde de deutérium, 100% atomique D, 7,5 ml, emballage en verreamp.

5-Bromo-8-fluoro-1,2,3,4-tetrahydronaphthalene, 97%, 100mg

7-Chloroisobenzofuran-1(3H)-one, 95.0%, 100mg

1-BUTANOL, 4,4,4-TRIFLUORO-3-(TRIFLUOROMETHYL)-, 95.0%, 250mg

5,7-Difluorochroman-4-ol, 95%, 100mg

3,5-DIFLUORO-N-METHYLBENZAMIDE, 95%, 1g

2-Chlorodibenzo[b,f][1,4]oxazepin-11(10H)-one, 95.0%, 1g

Colonne HPLC NUCLEODUR® 100-3 C8 ec, 250 mm, 4 mm, 1 pièce(s)